Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Abbott Laboratories (ABT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
6,022.00 +156.50    +2.67%
20/10 - Closed. Currency in ARS ( Disclaimer )
Type:  Equity
Market:  Argentina
ISIN:  ARDEUT110608 
  • Volume: 347
  • Bid/Ask: 6,022.00 / 6,060.00
  • Day's Range: 5,955.00 - 6,080.00
Abbott Laboratories 6,022.00 +156.50 +2.67%
Period Ending: 2021
30/06
2021
31/03
2020
31/12
2020
30/09
Total Current Assets 22627 21817 20441 17390
Cash and Short Term Investments 8944 8372 7148 4731
Cash - - - -
Cash & Equivalents 8658 8054 6838 4480
Short Term Investments 286 318 310 251
Total Receivables, Net 6113 6096 6414 5649
Accounts Receivables - Trade, Net 6113 6096 6414 5649
Total Inventory 5439 5387 5012 5152
Prepaid Expenses 2131 1962 1867 1858
Other Current Assets, Total - - - -
Total Assets 73269 72785 72548 69043
Property/Plant/Equipment, Total - Net 8816 8832 9029 8620
Property/Plant/Equipment, Total - Gross 19074 18697 18793 17972
Accumulated Depreciation, Total -10258 -9865 -9764 -9352
Goodwill, Net 23485 23384 23744 23338
Intangibles, Net 13681 14181 14784 15208
Long Term Investments 805 832 821 803
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 3855 3739 3729 3684
Other Assets, Total - - - -
Total Current Liabilities 12614 12462 11907 10257
Accounts Payable 4017 4066 3946 3189
Payable/Accrued - - - -
Accrued Expenses 6602 6364 6581 6098
Notes Payable/Short Term Debt 199 199 213 208
Current Port. of LT Debt/Capital Leases 755 756 7 6
Other Current liabilities, Total 1041 1077 1160 756
Total Liabilities 39469 39223 39764 37657
Total Long Term Debt 17547 17489 18527 18349
Long Term Debt 17547 17489 18527 18349
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest 229 226 219 209
Other Liabilities, Total 9079 9046 9111 8842
Total Equity 33800 33562 32784 31386
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 24153 24023 24145 24037
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) 29053 28669 27627 26266
Treasury Stock - Common -10340 -9845 -10042 -9873
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -9066 -9285 -8946 -9044
Total Liabilities & Shareholders' Equity 73269 72785 72548 69043
Total Common Shares Outstanding 1772.82 1776.82 1771.23 1772.36
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABT Comments

Write your thoughts about Abbott Laboratories
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email